Enanta Pharmaceuticals, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | -$1.34 | -$1.34 | -$1.34 |
Q2 2024 | 3 | -$1.43 | -$1.43 | -$1.43 |
Q3 2024 | 5 | -$1.50 | -$0.70 | -$1.16 |
Q4 2024 | 3 | -$1.10 | -$1.10 | -$1.10 |
Q1 2025 | 4 | -$1.32 | -$1.32 | -$1.32 |
Q2 2025 | 4 | -$1.40 | -$1.40 | -$1.40 |
Q3 2025 | 4 | -$1.45 | -$1.45 | -$1.45 |
Enanta Pharmaceuticals, Inc. Earnings Date And Information
Enanta Pharmaceuticals, Inc. last posted its earnings results on Monday, August 5th, 2024. The company reported $-1.07 earnings per share for the quarter, topping analysts' consensus estimates of $-1.49 by $0.42. The company had revenue of 17.97 M for the quarter and had revenue of 79.20 M for the year. Enanta Pharmaceuticals, Inc. has generated $-6 earnings per share over the last year ($-6.38 diluted earnings per share) and currently has a price-to-earnings ratio of -1.9. Enanta Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 25th, 2024 based on prior year's report dates.
Enanta Pharmaceuticals, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/07/2024 | Q3 2024 | -$1.07 | $17.44 M | $17.97 M | ||
05/08/2024 | Q2 2024 | -$1.47 | $17.05 M | |||
02/08/2024 | Q1 2024 | -$1.58 | $18.00 M | |||
11/22/2023 | Q4 2023 | -$1.33 | $17.49 M | $18.93 M | ||
08/08/2023 | Q3 2023 | -$1.86 | $18.19 M | $18.89 M | ||
05/09/2023 | Q2 2023 | -$1.79 | $17.80 M | |||
02/08/2023 | Q1 2023 | -$1.39 | $23.59 M | |||
11/23/2022 | Q4 2022 | -$1.28 | $23.13 M | $20.32 M | ||
08/08/2022 | Q3 2022 | -$1.36 | -$1.53 | -0.17 | $19.48 M | |
05/09/2022 | Q2 2022 | -$1.43 | -$1.62 | -0.19 | $18.72 M | |
02/09/2022 | Q1 2022 | -$1.48 | $27.37 M | $27.65 M | ||
11/24/2021 | Q4 2021 | -$1.22 | $26.34 M | $23.58 M | ||
08/09/2021 | Q3 2021 | -$1.19 | $21.86 M | $21.62 M | ||
05/10/2021 | Q2 2021 | -$1.09 | $20.13 M | |||
02/09/2021 | Q1 2021 | -$0.41 | $27.73 M | $31.74 M | ||
11/25/2020 | Q4 2020 | -$1.46 | $25.55 M | $23.63 M | ||
08/10/2020 | Q3 2020 | -$0.71 | $26.32 M | $18.65 M | ||
05/11/2020 | Q2 2020 | -$0.30 | $27.62 M | |||
02/10/2020 | Q1 2020 | $0.68 | $58.07 M | $52.57 M | ||
11/27/2019 | Q4 2019 | $0.47 | $55.94 M | $51.31 M |
Enanta Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Enanta Pharmaceuticals, Inc.'s earnings date?
Enanta Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 25th, 2024 based off last year's report dates.
-
Did Enanta Pharmaceuticals, Inc. beat their earnings estimates last quarter?
In the previous quarter, Enanta Pharmaceuticals, Inc. (:ENTA) reported $-1.07 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.49 by $0.42.
-
How can I listen to Enanta Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Enanta Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Enanta Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Enanta Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much revenue does Enanta Pharmaceuticals, Inc. generate each year?
Enanta Pharmaceuticals, Inc. (:ENTA) has a recorded annual revenue of $79.20 M.
-
How much profit does Enanta Pharmaceuticals, Inc. generate each year?
Enanta Pharmaceuticals, Inc. (:ENTA) has a recorded net income of $79.20 M. Enanta Pharmaceuticals, Inc. has generated $-6.38 earnings per share over the last four quarters.
-
What is Enanta Pharmaceuticals, Inc.'s price-to-earnings ratio?
Enanta Pharmaceuticals, Inc. (:ENTA) has a price-to-earnings ratio of -1.9 and price/earnings-to-growth ratio is 0.24.